A new blood test developed by neuroscientists can reveal whether Alzheimer's is affecting a patient's memory, providing crucial insights for early diagnosis and treatment. This innovation could transform how we understand and address Alzheimer's disease.
Discover the inspiring journeys of Kaileigh Baia and Jennifer Gansler as they navigate the challenges of long COVID. Their experiences shed light on the lasting impacts of the virus and the path to recovery.
A groundbreaking study from Washington University reveals that new Alzheimer’s medications could extend patient independence by up to 13 months. Discover how these findings reshape treatment decisions.
Study shows that new Alzheimer's drugs lecanemab and donanemab can significantly extend the period of independent living for patients with early-stage Alzheimer's disease, highlighting potential benefits and risks.
A recent study reveals that common antidepressants prescribed to dementia patients could be accelerating cognitive decline and increasing the risk of fractures and mortality. Find out the shocking implications for dementia care.
